A comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes.

Joseph TibaldiMartin Hadley-BrownAndreas LieblSteffen HaldrupViktor SandbergMichael L WoldenHelena W Rodbard

Published in: Diabetes, obesity & metabolism (2019)

Significantly improved HbA1c, larger reductions in rates and likelihood of hypoglycaemia and lower risk of treatment discontinuation were demonstrated with degludec vs glargine U300.

Keyphrases

type diabetes
glycemic control
adipose tissue
weight loss